Therapeutic choices in cancer of the elderly

Archives of Gerontology and Geriatrics

Volumn 22, Issue SUPPL.1, 1996, Pages 499-504

  Malaguarnera, M ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Cancer therapy in elderly; Chemotherapy of cancer; Immunotherapy of cancer

Indexed keywords

ANTINEOPLASTIC AGENT; INTERFERON; INTERLEUKIN 2;

AGED; AGING; ANALGESIA; ARTICLE; CANCER; CANCER IMMUNOTHERAPY; CANCER PATIENT; CANCER RECURRENCE; CANCER THERAPY; DRUG MEGADOSE; ELDERLY CARE; HUMAN; MEDICAL DECISION MAKING; PALLIATIVE THERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; SIDE EFFECT; SOLID TUMOR; TREATMENT PLANNING;

EID: 0343026605     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/0167-4943(96)86989-5     Document Type: Article

References (23)

1. ASI (Annuario Statistico Italiano 1951-1986) (1987): ISTAT Publication, Roma (in Italian).
2. Balducci, L. (1994): Strategies to improve the toxicity of antineoplastic treatment in the older person. Second International Conference on Geriatric Oncology, Genova, 19-21/9/1994 (abstract only).
3. Balducci, L., Beghe C., Chausmer, A. and Parker, M. (1991): Prognostic evaluation in geriatric oncology. Arch. Gerontol. Geriatr., 13, 31-41.
4. Calvert, H. (1994): Age and the pharmacology of antineoplastic agents. Second International Conference on Geriatric Oncology. Genova, 19-21/9/1994 (abstract only).
5. Clason, A.E., Duarte, A.J., Kupiec-Weglinski, J.W., Williams, J.N., Wang, B.S., Strom, T.B. and Tilney, N.L. (1982): Restoration of allograft responsiveness in B rats by interleukin-2 and/or adherent cells. J. Immunol., 129, 252-259.
6. Harousseau, J.L. (1993): Is intensive treatment beneficial to elderly patients? Hematol. Oncology, 11 (suppl. 1), 4-8.
7. Hogarty, G.E., McEvoy, J.P., Munetz, M. and the Evironmental/Personal Indicators in the Course of Schizophrenia Research Group (1988): Dose of fenphenazine familial expressed emotion and outcome in schizophrenia. Arch. Gen. Psychiatr., 45, 797-799.
8. Holmes, F.F. (1989): Clinical evidence for a change in tumor aggressiveness with age. Semin. Oncol., 16, 34-40.
9. Hrinyuk, W.M., Figuredo, A. and Goodyear, M. (1987): Applications of dose intensity to problems in chemotherapy of Breast and Colorectal Cancer. Semin. Oncol., 16, 34-40.
10. INS (Istituto Nazionale di Statistica) (1994) : Nascite e decessi anno 1991. Suppl. Annuario Statistico Italiano, 4, Roma (in Italian).
11. Klasa, R., Murray, N. and Goldman, J. (1991): Dose intensity meta-analysis of chemotherapy regimens in small-cell carcinoma of the lung. J. Clin. Oncol., 9, 499-508.
12. Liberati, A., Patterson, W.B., Biener, L. and McNeil, B.J. (1987): Determinants of physicians' preferences for alternative treatments in women with early breast cancer. Tumori, 73, 601-609.
13. Lyman, G.H. (1992): Decision analysis: a way of thinking about health care in the elderly. In: L. Balducci, G.H. Lyman and W.B. Ershler (editors): Geriatric Oncology, pp.: 8-18, J.B. Lippincott Co., Philadelphia.
14. Monfardini, S. and Yancik, R. (1993): Cancer in the elderly: meeting the challenge of an aging population. J. Nat. Cancer Inst., 85, 532-538.
15. Merluzzi, V.J., Kenney, R.E., Schmid, F.A., Choi, Y.S. and Fannes, R.B. (1981): Recovery of the in vivo cytotoxic T-cell response in cyclophosphamide-treated mice by injection of mixed-lymphocyte-culture supernatants. Cancer Res., 41, 3663-3665.
16. Powell, B.L., Capizzi, R.I., Muss, H.B., Bearden, J.D., Lyerly, E.S., Rosenbaum, D.L., Morgan, T.M., Richards, F., Jackson, D.V., White, D.R., Nelson, E.C., Buttler, W.M., Zekan, P.J., Cruz, J.M., Cooper, R., Buss, D.H. and Spurr, C.L. (1989): Low dose Ara-C therapy for acute myelogenous leukemia in elderly patients. Leukemia, 3, 23-28.
17. Rosen, S.T., Benson III, A.B., Kuzel, T. and Tallman, M.S. (1992): Biologic therapies in cancer patients: Implications for treatment in older patients. In: L. Balducci, G.H. Lyman and W.B. Ershler (editors): Geriatric Oncology, pp.: 181-187, J.B. Lippincott Co., Philadelphia.
18. Samet, J., Hunt, W.C., Key, C., Humble, C.G. and Goodwin, J.S. (1986): Choice of cancer therapy varies with age of patient. J. Amer. Med. Assoc., 225, 3385-3390.
19. SEER Program (1984): Cancer incidence and mortality in the United States 1973-1981. NIH Publication No. 85-1837. pp.: 56-58, US Government Printing Office, Washington, DC.
20. Talpaz, M., McCredie, K.B., Mavlight, G.M. and Gutterman, J.U. (1983): Leukocyte interferon-induced myeloid cytoreduction in chronic myelogenous leukemia. Blood, 62, 689-692.
21. Tilly, H., Castaigne, S., Bordessoule, D., Casassus, P., Le Prise, P.Y., Tertian, G., Desablens, B., Henry-Amar, M. and Degos, L. (1990): Lowdose cytarabine versus intensive chemotherapy in the treatment of acute nonlymphocytic leukemia in the elderly. J. Clin. Oncol., 8, 272-279.
22. Yancik, R. and Ries, L.A. (1994): Cancer in older persons. Cancer, 74, 1995-2003.
23. Wood, W.C., Budman, D.R. and Korzun, A.M. (1994): Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast cancer. New Engl. J. Med., 330, 1253-1259.